CO DIOVAN

Co Diovan Adverse Events Reported to the FDA Over Time

How are Co Diovan adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Co Diovan, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Co Diovan is flagged as the suspect drug causing the adverse event.

Most Common Co Diovan Adverse Events Reported to the FDA

What are the most common Co Diovan adverse events reported to the FDA?

Blood Pressure Increased	28 (1.57%)
Blood Pressure Inadequately Control...	26 (1.45%)
Blood Creatinine Increased	24 (1.34%)
Fall	23 (1.29%)
Hypertension	23 (1.29%)
Hypotension	23 (1.29%)
Hyponatraemia	22 (1.23%)
Drug Ineffective	21 (1.17%)
Dizziness	19 (1.06%)
Arrhythmia	16 (.89%)
Condition Aggravated	16 (.89%)
	Show More
Death	16 (.89%)
Microalbuminuria	16 (.89%)
Myocardial Infarction	15 (.84%)
Pneumonia	15 (.84%)
Angina Pectoris	12 (.67%)
Oedema Peripheral	12 (.67%)
Syncope	12 (.67%)
Blood Creatine Phosphokinase Increa...	11 (.62%)
Cerebral Haemorrhage	11 (.62%)
Chest Pain	11 (.62%)
Malaise	11 (.62%)
Pruritus	11 (.62%)
Vomiting	11 (.62%)
Asthenia	10 (.56%)
Blood Glucose Increased	10 (.56%)
Cerebral Infarction	10 (.56%)
Chest Discomfort	10 (.56%)
Dyspnoea	10 (.56%)
Erythema	10 (.56%)
Headache	10 (.56%)
Renal Failure	10 (.56%)
Anaemia	9 (.5%)
Anxiety	9 (.5%)
Blood Pressure Decreased	9 (.5%)
Blood Sodium Decreased	9 (.5%)
Cerebrovascular Accident	9 (.5%)
Drug Interaction	9 (.5%)
Gamma-glutamyltransferase Increased	9 (.5%)
Hyperkalaemia	9 (.5%)
Pain In Extremity	9 (.5%)
Pyrexia	9 (.5%)
Swelling	9 (.5%)
Arthralgia	8 (.45%)
Blood Potassium Decreased	8 (.45%)
Muscular Weakness	8 (.45%)
Somnolence	8 (.45%)
Weight Decreased	8 (.45%)
Arthritis	7 (.39%)
Aspartate Aminotransferase Increase...	7 (.39%)
Blood Pressure Diastolic Decreased	7 (.39%)
Blood Urea Increased	7 (.39%)
Circulatory Collapse	7 (.39%)
Decreased Appetite	7 (.39%)
Dehydration	7 (.39%)
Diabetes Mellitus	7 (.39%)
Feeling Abnormal	7 (.39%)
Haematoma	7 (.39%)
Hemiplegia	7 (.39%)
Loss Of Consciousness	7 (.39%)
Renal Disorder	7 (.39%)
Renal Failure Acute	7 (.39%)
Abdominal Discomfort	6 (.34%)
Abdominal Pain Upper	6 (.34%)
Alanine Aminotransferase Increased	6 (.34%)
Back Pain	6 (.34%)
Blood Bilirubin Increased	6 (.34%)
Blood Uric Acid Increased	6 (.34%)
Cardiac Disorder	6 (.34%)
Constipation	6 (.34%)
Depression	6 (.34%)
Diarrhoea	6 (.34%)
Fatigue	6 (.34%)
Gait Disturbance	6 (.34%)
Hyperhidrosis	6 (.34%)
Hypokalaemia	6 (.34%)
Limb Discomfort	6 (.34%)
Rhabdomyolysis	6 (.34%)
Urticaria	6 (.34%)
Blister	5 (.28%)
Blood Lactate Dehydrogenase Increas...	5 (.28%)
Concomitant Disease Aggravated	5 (.28%)
Cough	5 (.28%)
Dysphagia	5 (.28%)
Eczema	5 (.28%)
Epistaxis	5 (.28%)
Haemoglobin Decreased	5 (.28%)
Hepatic Failure	5 (.28%)
Hyperuricaemia	5 (.28%)
Muscular Dystrophy	5 (.28%)
Nasopharyngitis	5 (.28%)
Normochromic Normocytic Anaemia	5 (.28%)
Pancreatitis Acute	5 (.28%)
Septic Shock	5 (.28%)
Speech Disorder	5 (.28%)
Asphyxia	4 (.22%)
Asthma	4 (.22%)
Blood Alkaline Phosphatase Increase...	4 (.22%)
Bradycardia	4 (.22%)
Bronchitis	4 (.22%)
Cardiac Arrest	4 (.22%)

Share/Embed Graph Export Data

This graph shows the top adverse events submitted to the FDA for Co Diovan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Co Diovan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Co Diovan

What are the most common Co Diovan adverse events reported to the FDA?

Neurological	76 (4.25%)
Epidermal And Dermal Conditions	68 (3.8%)
Decreased And Nonspecific Blood Pre...	60 (3.36%)
Cardiac And Vascular Investigations	57 (3.19%)
Hematology Investigations	56 (3.13%)
Infections - Pathogen Unspecified	54 (3.02%)
Electrolyte And Fluid Balance Condi...	53 (2.96%)
Renal And Urinary Tract Investigati...	43 (2.4%)
Respiratory	41 (2.29%)
Cardiac Arrhythmias	40 (2.24%)
Gastrointestinal Signs	40 (2.24%)
	Show More
Hepatobiliary	38 (2.13%)
Central Nervous System Vascular	37 (2.07%)
Injuries	36 (2.01%)
Renal Disorders	32 (1.79%)
Joint	31 (1.73%)
Musculoskeletal And Connective Tiss...	31 (1.73%)
Coronary Artery	30 (1.68%)
Therapeutic And Nontherapeutic Effe...	30 (1.68%)
Bone And Joint Injuries	28 (1.57%)
Water, Electrolyte And Mineral	28 (1.57%)
Urinary Tract Signs	27 (1.51%)
Vascular Hypertensive	27 (1.51%)
Muscle	26 (1.45%)
Enzyme	24 (1.34%)
Hepatic And Hepatobiliary	23 (1.29%)
Metabolic, Nutritional And Blood Ga...	21 (1.17%)
Anemias Nonhemolytic And Marrow Dep...	18 (1.01%)
Gastrointestinal Motility And Defec...	17 (.95%)
Fatal Outcomes	16 (.89%)
Movement Disorders	15 (.84%)
Anxiety Disorders	13 (.73%)
Glucose Metabolism Disorders	13 (.73%)
Lower Respiratory Tract Disorders	13 (.73%)
Skin Appendage Conditions	13 (.73%)
Headaches	12 (.67%)
Upper Respiratory Tract Disorders	12 (.67%)
Cardiac Disorder Signs	11 (.62%)
Gastrointestinal Hemorrhages	11 (.62%)
Vascular Hemorrhagic	11 (.62%)
Appetite And General Nutritional	10 (.56%)
Body Temperature Conditions	9 (.5%)
Medication Errors	9 (.5%)
Musculoskeletal And Connective Tiss...	9 (.5%)
Physical Examination Topics	9 (.5%)
Gastrointestinal Ulceration And Per...	8 (.45%)
Immunology And Allergy	8 (.45%)
Pleural	8 (.45%)
Vascular	8 (.45%)
Vision	8 (.45%)
Arteriosclerosis, Stenosis, Vascula...	7 (.39%)
Dental And Gingival Conditions	7 (.39%)
Depressed Mood Disorders	7 (.39%)
Gastrointestinal Neoplasms Malignan...	7 (.39%)
Lifestyle Issues	7 (.39%)
Musculoskeletal And Connective Tiss...	7 (.39%)
Thyroid Gland	7 (.39%)
White Blood Cell	7 (.39%)
Angiedema And Urticaria	6 (.34%)
Chemical Injury And Poisoning	6 (.34%)
Exocrine Pancreas Conditions	6 (.34%)
Heart Failures	6 (.34%)
Investigations, Imaging And Histopa...	6 (.34%)
Lipid Metabolism	6 (.34%)
Purine And Pyrimidine Metabolism	6 (.34%)
Red Blood Cell	6 (.34%)
Therapeutic Procedures And Supporti...	6 (.34%)
Bronchial Disorders	5 (.28%)
Cardiac Valve	5 (.28%)
Endocrine Investigations	5 (.28%)
Eye	5 (.28%)
Eye Therapeutic Procedures	5 (.28%)
Gallbladder	5 (.28%)
Gastrointestinal Inflammatory Condi...	5 (.28%)
Hearing	5 (.28%)
Inner Ear And Viiith Cranial Nerve	5 (.28%)
Lipid Analyses	5 (.28%)
Nervous System, Skull And Spine The...	5 (.28%)
Protein And Chemistry Analyses	5 (.28%)
Skin Vascular Abnormalities	5 (.28%)
Suicidal And Self-injurious Behavio...	5 (.28%)
Anterior Eye Structural Change, Dep...	4 (.22%)
Bacterial Infectious	4 (.22%)
Cardiac Therapeutic Procedures	4 (.22%)
Cranial Nerve Disorders	4 (.22%)
Platelet	4 (.22%)
Schizophrenia And Other Psychotic	4 (.22%)
Allergic Conditions	3 (.17%)
Benign Neoplasms Gastrointestinal	3 (.17%)
Bone Disorders	3 (.17%)
Connective Tissue Disorders	3 (.17%)
Embolism And Thrombosis	3 (.17%)
Hematological And Lymphoid Tissue T...	3 (.17%)
Hypothalamus And Pituitary Gland	3 (.17%)
Miscellaneous And Site Unspecified ...	3 (.17%)
Mood Disorders	3 (.17%)
Myocardial	3 (.17%)
Obstetric And Gynecological Therape...	3 (.17%)
Peritoneal And Retroperitoneal Cond...	3 (.17%)
Pulmonary Vascular	3 (.17%)
Renal And Urinary Tract Neoplasms M...	3 (.17%)

Share/Embed Graph Export Data

This graph shows the top categories of adverse events submitted to the FDA for Co Diovan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Co Diovan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.